tanshinone has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C; Liu, H; Shi, G; Sun, D; Tan, X; Wang, M; Zhang, P; Zhu, P | 1 |
1 other study(ies) available for tanshinone and Bile Duct Cancer
| Article | Year |
|---|---|
Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Humans; Male; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2021 |